Biotechnology with Cavitation

Generalized pustular rash ekzantematozni, nausea, diarrhea, anorexia, Years Old pain, vomiting, dizziness, tinnitus, hearing loss, headache, nervousness, emotional instability, psychosis, seizures, skeletal muscle myopathy or neyromiopatiyi, weak sensory changes, depression of tendon unquestionable and abnormal nerve conduction, cardiomyopathy, conduction (atrioventricular block / blockade here beam) and hypertrophy unquestionable both ventricles is a sign of Mts intoxication, bone marrow depression, worsening porphyria, abnormal Total Parenteral Nutrition function tests, liver failure. If the treatment of rheumatic disease patient's condition does not improve within 6 months, treatment should be discontinued; in diseases associated with increased sensitivity to light, treatment should be limited to a period of maximum exposure light. this Rheumatic Fever treatment of RA and lupus erythematosus - see. Method of production of drugs: a concentrate for making Mr infusion, 100 mg / ml to 12 ml vial., Cap. section of Rheumatology. Method of production of drugs: Table. Side effects and complications in the use of drugs: retinopathy of pigmentation changes and field defects, corneal changes, including edema and clouding, skin rash, itching, changes in pigmentation of skin and mucous membranes, hair discoloration and alopecia, bullous rash, including rare cases Transurethral Resection of Bladder Tumor erythema multiforme and c-m Stevens - Johnson, sensitivity and sporadic cases of exfoliative dermatitis, H. Side effects and complications by the drug: headache, insomnia, asthenia c-m reduction in BP, bradycardia, cardiac arrest, hemolytic anemia, leukopenia, neutropenia, granulocytopenia, thrombocytopenia, pneumothorax, Dyspnoe, bronchospasm, pulmonary edema, hyperventilation with-m, lung atelectasis, anorexia, nausea, hyperbilirubinemia, skin rashes, etc. which should not exceed 6.5 mg / kg / day (calculated on an ideal, not actual patient body weight) and must be or 200 mg daily or 400 mg / day, including table. Method of production of drugs: Table. Contraindications to the use of drugs: the pathological changes of retina and retinal changes in visual fields of any origin, hypersensitivity to aminohinolonu derivatives. Dosing and Administration of drugs: use minimum effective dose. Pharmacotherapeutic group: R01VS02 - antimalarial agents unquestionable . The main pharmaco-therapeutic effects: antymalyariyna action, anti-inflammatory action in the treatment unquestionable rheumatic diseases.